A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Recruiting now

Conditions studied: Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures

In brief

The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[including secondarily generalized seizures\]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).

Key facts

Study ID

NCT06657378

Run by

Eisai Co., Ltd.

People needed

110

Starts

2024-11-18

Expected to finish

2028-06-15

Last updated by the study team

2026-07-01

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with epilepsy who received the Fycompa for injection for the first time will be included.

You may not qualify if…

• The exclusion criteria will not be specified in particular because this survey will be conducted in daily clinical practice.

Where it is running

• 1 — Tokyo, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.